Arthur Fratamico
Director/Board Member at PANBELA THERAPEUTICS, INC.
Net worth: - $ as of 30/04/2024
Network origin in Arthur Fratamico first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 19 | |
| Public Company | Pharmaceuticals: Major | 15 | |
| Subsidiary | Pharmaceuticals: Major | 4 | |
Radiant Biotherapeutics, Inc.
 Radiant Biotherapeutics, Inc. BiotechnologyHealth Technology Radiant Biotherapeutics, Inc. develops multi-valent and specific bio therapeutics solutions. Arthur J. Fratamico has been the CEO of the Canadian company since 2021.
1
| Holding Company | Biotechnology | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Arthur Fratamico via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Director of Finance/CFO Comptroller/Controller/Auditor | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | General Counsel Chief Operating Officer | |
| CHIMERIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| ZELTIQ AESTHETICS INC | Medical Specialties | Director/Board Member Chief Executive Officer | |
| CANCER PREVENTION PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal | |
| Stanford University | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree | |
| Boston College | College/University | Undergraduate Degree Graduate Degree | |
| St. Joseph's University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Arizona | College/University | Undergraduate Degree Undergraduate Degree | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Southern Minnesota Beet Sugar Cooperative
 Southern Minnesota Beet Sugar Cooperative Agricultural Commodities/MillingProcess Industries Southern Minnesota Beet Sugar Cooperative is engaged in producing, processing, and supplying granulated sugar and liquid sugar products. The firm offers refined sugar, liquid sugar, granulated sugar, fruit sugar, liquid sucrose, and baker's sugar. The company was founded in 1971 and is headquartered in Renville, MN. | Agricultural Commodities/Milling | Corporate Officer/Principal Corporate Officer/Principal | |
Breakaway Technologies, Inc.
 Breakaway Technologies, Inc. Packaged SoftwareTechnology Services Breakaway Technologies, Inc. develops analytic and business intelligence software. The private company is based in Yardley, PA. The company was founded by Darby Williams. | Packaged Software | Director of Finance/CFO | |
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | President Treasurer Corporate Secretary | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
Tyree & D’Angelo Partners Management LP
 Tyree & D’Angelo Partners Management LP Investment ManagersFinance Tyree & D’Angelo Partners Management LP(Tyree & D’Angelo Partners Management) is a private equity firm founded in 2013 by James L. Tyree, Enzo D’Angelo and Michael Tyree. The firm is headquartered in Chicago, Illinois. | Investment Managers | Private Equity Investor | |
| College of Pharmacy | College/University | Undergraduate Degree Undergraduate Degree | |
| VIKING THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Corporate Secretary | |
IFM Therapeutics LLC
 IFM Therapeutics LLC Pharmaceuticals: MajorHealth Technology IFM Therapeutics LLC engages in the development and transformation of immunotherapy for patients with serious diseases. It focuses on developing small molecule drugs that target the innate immune system. The company was founded by Gary D. Glick, Luigi Franchi, Matthias Geyer, Eicke Latz, and Anthony W. Opipari, Jr. in 2015 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
| IQVIA HOLDINGS INC. | Services to the Health Industry | Director/Board Member | |
Sun Biopharma Research, Inc.
 Sun Biopharma Research, Inc. BiotechnologyHealth Technology Sun Biopharma Research, Inc. is an American biopharmaceutical company that operates in the field of biopharmaceuticals. The private company was founded by Michael T. Cullen. | Biotechnology | Founder Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
3T Biosciences, Inc.
 3T Biosciences, Inc. BiotechnologyHealth Technology 3T Biosciences, Inc. operates as immunotherapy company. The company was founded by Luke J. Lee, Marvin Gee and Leah Sibener and is headquartered in Palo Alto, CA. | Biotechnology | Director/Board Member | |
Context Therapeutics LLC
 Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director of Finance/CFO President | |
IFM Cinque, Inc.
 IFM Cinque, Inc. Miscellaneous Commercial ServicesCommercial Services IFM Cinque, Inc. is a biotechnology company. The company is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
IFM Continua, Inc.
 IFM Continua, Inc. BiotechnologyHealth Technology IFM Continua, Inc. engages in the provision of biotechnology services. The company is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
IFM Quattro, Inc.
 IFM Quattro, Inc. Miscellaneous Commercial ServicesCommercial Services IFM Quattro, Inc. is a biotechnology company. The company is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| LARIMAR THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer |
Statistics
International
| United States | 50 |
| Canada | 2 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 12 |
| Commercial Services | 5 |
| Process Industries | 3 |
| Technology Services | 2 |
Operational
| Director/Board Member | 245 |
| Independent Dir/Board Member | 78 |
| Corporate Officer/Principal | 70 |
| Chairman | 50 |
| Director of Finance/CFO | 40 |
Most connected contacts
| Insiders | |
|---|---|
| Bryan Roberts | 44 |
| Heath Lukatch | 43 |
| Peter Barrett | 38 |
| Ambrose Bailey | 32 |
| Charles Newhall | 29 |
| Gino Santini | 26 |
| Charles Rowland | 25 |
| Donald Hayden | 23 |
| Fred Driscoll | 21 |
| Jeffrey Hatfield | 18 |
| Robert Gunderson | 17 |
| John Leonard | 17 |
| Jeffrey Mathiesen | 13 |
| Thomas Neenan | 12 |
| Scott Applebaum | 11 |
- Stock Market
- Insiders
- Arthur Fratamico
- Company connections